Investing in Vivos Therapeutics Inc (VVOS) is a safe bet with a significant edge

Vivos Therapeutics Inc (NASDAQ: VVOS) closed the day trading at $4.83 up 3.87% from the previous closing price of $4.65. In other words, the price has increased by $+0.2700 from its previous closing price. On the day, 77041 shares were traded.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Ratios:

For a better understanding of VVOS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.28 and its Current Ratio is at 0.28. In the meantime, Its Debt-to-Equity ratio is 42.00 whereas as Long-Term Debt/Eq ratio is at 32.80.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 20 ’23 when Huntsman Ronald Kirk bought 14,000 shares for $0.53 per share. The transaction valued at 7,420 led to the insider holds 86,521 shares of the business.

Huntsman Ronald Kirk bought 15,000 shares of VVOS for $8,050 on Jun 16 ’23. The Chief Executive Officer now owns 72,521 shares after completing the transaction at $0.54 per share. On Jun 15 ’23, another insider, Huntsman Ronald Kirk, who serves as the Chief Executive Officer of the company, bought 21 shares for $0.50 each. As a result, the insider paid 10 and bolstered with 57,521 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VVOS now has a Market Capitalization of 6.19M and an Enterprise Value of 7.31M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.44 while its Price-to-Book (P/B) ratio in mrq is 125.72. Its current Enterprise Value per Revenue stands at 0.50 whereas that against EBITDA is -0.42.

Stock Price History:

Over the past 52 weeks, VVOS has reached a high of $48.79, while it has fallen to a 52-week low of $2.73. The 50-Day Moving Average of the stock is 5.3518, while the 200-Day Moving Average is calculated to be 7.7550.

Shares Statistics:

Over the past 3-months, VVOS traded about 117.91K shares per day on average, while over the past 10 days, VVOS traded about 61.06k shares per day. A total of 1.33M shares are outstanding, with a floating share count of 1.13M. Insiders hold about 15.22% of the company’s shares, while institutions hold 19.20% stake in the company. Shares short for VVOS as of Mar 15, 2024 were 26.18k with a Short Ratio of 0.22, compared to 29.16k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.97% and a Short% of Float of 2.27%.

Most Popular